Cryo-Cell International, Inc. (CCEL)
After hours:
| Previous Close | 7.46 |
| Open | 7.43 |
| Bid | 8.15 x 900 |
| Ask | 8.38 x 1000 |
| Day's Range | 7.47 - 8.48 |
| 52 Week Range | 3.67 - 9.50 |
| Volume | |
| Avg. Volume | 12,354 |
| Market Cap | 67.173M |
| Beta (5Y Monthly) | 0.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.07 |
| Earnings Date | Oct 15, 2024 |
| Forward Dividend & Yield | 1.00 (13.40%) |
| Ex-Dividend Date | Nov 15, 2024 |
| 1y Target Est | 9.00 |
Business WireCord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
OLDSMAR, Fla., October 30, 2024--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) ("Cryo-Cell"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that its Board of Directors has approved the payment of a regular quarterly cash dividend at an initial rate of $0.25 per share of common stock to be paid to its shareholders of record as of the close of business on November 15, 2024. The dividend is expected to be paid on November 29, 20
Business WireCord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results
OLDSMAR, Fla., October 15, 2024--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2024.
